"Leishmaniasis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with LEISHMANIA.
| Descriptor ID |
D054332
|
| MeSH Number(s) |
D20.215.894.582.480
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis Vaccines".
This graph shows the total number of publications written about "Leishmaniasis Vaccines" by people in this website by year, and whether "Leishmaniasis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2020 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis Vaccines" by people in Profiles.
-
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani. Cytokine. 2024 02; 174:156475.
-
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. Protein Expr Purif. 2021 01; 177:105750.
-
Development and Characterization of an Avirulent Leishmania major Strain. J Immunol. 2020 05 15; 204(10):2734-2753.
-
Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as?a Leishmania Vaccine Candidate. J Pharm Sci. 2020 05; 109(5):1673-1680.
-
LmjMAPK10 offers protection against Leishmania donovani infection. Parasite Immunol. 2020 02; 42(2):e12687.
-
Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. Protein Expr Purif. 2017 02; 130:129-136.
-
Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016 06 03; 34(26):2992-2995.
-
The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine. 2013 Jan 07; 31(3):480-6.